Category: Becton Dickinson & Co.
Becton, Dickinson & Co. says Brazil's Secretariat of Foreign Trade is probing whether it dumped vacuum tubes onto the Brazilian market for less than their price in the U.S.
Becton Dickinson & Co. (NYSE:BDX) said a Brazilian agency today began an anti-dumping probe that's looking into sales in Brazil of its vacuum tubes used to collect blood.
Third-quarter losses mount for Retractable Technologies as sales decline 3%.
Retractable Technologies (NYSE:RVP) continued its descent into the red as 3rd-quarter losses mounted amid declining sales.
Becton Dickinson hands out promotions as it releases mixed Q4 earnings that best analysts' projections
Becton Dickinson & Co. (NYSE:BDX) beat Wall Street's estimates for its 4th quarter of 2013 and handed out a couple of promotions during the company's quarterly conference call with investors.
European regulators warn of increased incidence of Becton Dickinson catheters "buckling" during their initial insertion into patients' skin.
Becton Dickinson asks for another chance to make its case and overturn a $113.5 million loss to syringe rival Retractable Technologies.
Becton Dickinson & Co. pays out nearly $8 million to Retractable Technologies, ending the patent infringement portion of their long-running legal dispute.
A slate of medical device makers, including Becton Dickinson, Johnson & Johnson and Zoll, land federal contracts collectively worth nearly $370 million.
Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices.